Situated among one of the world’s largest neuroscience communities, the Massachusetts General Hospital provides an array of neurotherapeutic treatments for our varied patient populations. Experts from the Department of Neurology, Department of Neurosurgery, Department of Psychiatry, the Athinoula A. Martinos Center for Biomedical Imaging and beyond develop and implement neurotherapeutics and associated diagnostics for individuals with complex brain disorders affecting cognition, behavior, emotion, sensory and motor functioning.
The ALS Multidisciplinary Clinic in the Healey Center for ALS at Mass General provides personalized care and access to the latest treatments and research opportunities for people with ALS, commonly known as Lou Gehrig’s disease.
The Mass General Epilepsy Service offers diagnosis, treatment, and consultations for seizure disorders, including surgical evaluations, and specialized care for first seizure events.
Our lab, led by Bakhos Tannous, PhD, focuses on molecular imaging, gene transfer technologies and high throughput screening aiming at finding novel therapeutics against brain tumors.
Our lab is focused on understanding neural repair mechanisms and outcomes after stroke in order to guide the development and clinical translation of novel neurotechnologies to optimize stroke recovery.
The Movement Disorders Unit at Mass General sees patients from around the world for everything from the most common to the rarest of movement disorders.
The Dauten Family Center for Bipolar Treatment Innovation at Massachusetts General Hospital is dedicated to finding new treatments for bipolar disorder, providing high-quality clinical care and educating our colleagues, our patients, their families and the community about this disorder.
The Intravenous (IV) Ketamine Clinic for Depression at Massachusetts General Hospital offers patients and their professional providers access to ketamine treatment for severe and refractory depression.
The mission of the Pediatric Psychopharmacology and Adult ADHD Program at Massachusetts General Hospital is to advance the well-being of children and families afflicted with mental illness through research, education and clinical care.
The TMS Clinical Service at Massachusetts General Hospital provides non-invasive treatment for patients with major depressive disorder who are unable to find relief through antidepressant medications or psychotherapy.
Additional Neurotherapeutic Clinical Therapies and Research
The Mass General for Children Epilepsy Surgery Program provides surgical evaluation and treatment for pediatric patients whose epilepsy cannot be managed with medical therapy or those for whom surgery is the best option overall.
For several decades the Massachusetts General Hospital Department of Neurosurgery and Department of Neurology have led in patient care for those with Parkinson's disease and advancing clinical research to develop new treatments with the hope of creating a cure.
2,000 + Researchers
Unparalleled Research Capabilities
We push scientific boundaries by training the best minds in the world
500+ Biotech Companies
Massachusetts Biotech Ecosystem
Worlds largest concentration of biotechnology and research centers.
1,200 + CLINICAL TRIALS
Mass General has 1,200 clinical trials taking place at any given time.
Emerging research from the Clotilde Lagier-Tourenne Lab, in collaboration with Franck Martin's Lab at the University of Strasbourg, is shedding new light on how genetic mutations in the C9ORF72 gene cause ALS and frontotemporal dementia (FTD).
The PACT Program provides guidance to parents and grandparents with ALS on how to talk to children about the illness and support their healthy coping with it. Learn more.
The Sean M. Healey & AMG Center for ALS at Mass General Brigham awarded the seventh annual Sean M. Healey International Prize for Innovation in ALS to the team of researchers who discovered that nucleotide-repeat expansions can cause ALS, revealing disease mechanisms and therapeutic targets.
The Sean M. Healey & AMG Center at Massachusetts General Brigham awards the fifth annual Drs. Ayeez and Shelena Lalji & Family ALS Endowed Award for Innovative Healing to Dr. Frank Bradke.
The Sean M. Healey & AMG Center for ALS is pleased to announce that Cedric Böger, a PhD student at the German Center for Neurodegenerative Diseases (DZNE), has been awarded the 3rd annual Drs. Ayeez and Shelena Lalji & Family Student Scholar for Repair and Regenerative Mechanisms in ALS.
1of
6
Advances in Motion Neuroscience
Read the latest research coming from our research programs and laboratories from Mass General Neuroscience.